by admin | Jun 29, 2018 | Hot Topics
New technologies are poised to fundamentally change the HR industry as we know it. Just as the smartphone revolutionized the way we communicate, artificial intelligence will reshape all areas of HR, from employee onboarding to learning management to developing top talent. And, similar to smartphones, these changes will take place at lightning speed.
But what exactly is artificial intelligence? And what implications might this evolving tech have on the future of health care? Buckle up, because we’re going to take a glimpse into the current AI projects, as well as what the future of health care could look like with AI advancements.
What Is Artificial Intelligence?
In its most basic form, artificial intelligence uses computer programming to develop systems that are able to perform tasks that would normally require human intelligence. These tasks could include speech recognition, decision-making, language translation, and much more.
Have you ever wondered how ridesharing apps like Uber and Lyft are able to predict ETAs for rides? Artificial intelligence. Or, how email platforms know how to filter out spam and nicely categorize your emails into categories? Yep, artificial intelligence. Or, how your banking app is able to process a check deposit via a simple image? You guessed it, artificial intelligence.
Artificial intelligence has become an integral part of many of the technologies and services that we use in our everyday life without us even knowing or really thinking about it.
In addition to its many convenient applications, AI also offers a promising and impactful future in the field of health care.
Examples of Artificial Intelligence in Health Care
The use of artificial intelligence is completely altering the front door of health care as we know it. From specific programs that aid in medical diagnostics to intelligent apps that triage remote patients, AI is making health care more efficient and accessible than ever.
Medical Data Mining
One of the primary areas in which AI shines versus manual human processes in the field of data analysis. Not only can artificial intelligence process complex sets of data at lightning speed, it can also provide meaningful and actionable insight and recommendations based on data sets. DeepMind(acquired by Google in 2014) is an AI-based technology that works to expedite the process in which patients are moved from ‘test’ to ‘treatment’. IBM’s Watsonproduct provides solutions for interpreting, organizing, and easily accessing clinical and patient data, in addition to providing technology for recognizing patient similarity and medical insights. According to IBM, medical data is expected to double every 73 days by 2020. And, each person will generate enough health-related data in their lifetime to fill 300 million physical books. Utilizing AI will not only expedite the process in which health care providers access patient info but also better-organize and analyze data available and even provide predictions on future health concerns and recommendations for treatment plans.
Powering Diagnostics
The FDA recently approved the use of artificial intelligence powered software for the use of medical diagnostics, marking the first use of AI in this application. The program is designed to detect signs of diabetic retinopathy, a condition that can cause long-term vision loss and that impacts more than 30 million people in the United States alone. The technology uses an AI algorithm to scan and analyze multiple images of an eye and then delivers a positive or negative test result. This is the first FDA approved solution that does not require a doctor to interpret test results, and more AI-based diagnostic solutions are expected to get the green light in the next several years.
Drug Development
It’s no secret that testing pharmaceuticals through clinical trials is an expensive and time-consuming process. The full development, testing, and approval process can literally take decades and cost billions. Though pharmaceutical players of all sizes are currently experimenting with AI applications in the drug discovery and development process, GSK is considered a leader in the space. GSK has fully embraced AI research and applications with their dedicated in-house team, ‘In silico Drug Discovery Unit’. The ultimate goal of the GSK project is to leverage artificial intelligence to shorten the drug research, testing, and launch window to under a year, a bold vision. Making the pharmaceutical process more efficient could drastically reduce the cost of medical treatments and the cost of health care in general.
Solving Doctor Shortages
China is facing one of the most alarming doctor shortagesin history, with only 1.5 doctors for every 1,000 residents (compared to 2.5 doctors per person in the United States). The need is dire, and the government is calling for action and loosening restrictions on the use of data and new technology. Currently, more than 100 companies are working to develop AI solutions to address urgent health care needs. A recent reportpredicted that China’s market for AI-powered health care services will reach almost $6B yuan ($930 Million) by 2022. Current projects include diagnostic tools to assist with CT scans, x-rays, ultrasound scans and prosthetic design and manufacturing.
Improving Telemedicine
Which would you prefer – an hour-long wait in a doctor’s office plus the time to actually see the doctor, or a quick 15-minute consultation and diagnosis via your smartphone? Though many assume telemedicine is a modern iteration of health care, this practice has actually been around since the 1950’s. Now, telemedicine is a common alternative to traditional doctor’s visits for simple diagnostics and treatment. A new app, 98point6, is taking this remote-experience to the next level with artificial intelligence. The technology interacts with subscribers to help better understand medical needs and then channels requests to the appropriate doctor for evaluation. The AI-bot essentially serves as a personalized triage service, saving manual time and labor.
The Bottom Line?
The adoption and utilization of artificial intelligence in the health care space will make health care more accessible, efficient, and affordable for everyone.
by Meisha Bochicchio, Content Marketing Manager at PlanSource
Originally posted on blog.ubabenefits.com
by admin | Jun 27, 2018 | Compliance, Human Resources
NLRB: Guidance on Handbook Rules Post-Boeing
On June 8, 2018, National Labor Relations Board (NLRB) General Counsel, Peter B. Robb, released a memorandum (GC 18-04) providing guidance to regional offices under the NLRB’s decision in Boeing. Per Boeing, the NLRB evaluates facially neutral handbook policies and work rules by a balancing test of impact versus justification. Specifically, the potential impact of an employer’s (workplace and handbook) policies and work rules on employees NLRA-protected rights versus the employer’s legitimate justifications for maintaining the policy or rule.
This balancing test was broken down into the following three categories:
- Category 1: Rules that are generally lawful to maintain.
- Category 2: Rules warranting individualized scrutiny.
- Category 3: Rules that are unlawful to maintain.
In the memo, the general counsel provided in-depth guidance, along with application, of the three categories of rules for regional offices to use when investigating and processing cases. For example, regional offices were directed as follows:
- Ambiguities in work rules are no longer interpreted against the drafter (employer), and generalized provisions should not be interpreted as banning all activity that could conceivably be included.
- Well-established standards regarding certain kinds of work rules where the NLRB has already struck a balance between employee rights and employer business interests remain in place.
- The application of a facially neutral rule against employees engaged in protected concerted activity is still unlawful and a neutral handbook rule does not render protected activity unprotected.
Basically, the guidance provides insight as to how the holding in Boeing will be applied to workplace policies, rules, and company handbooks going forward.
Originally Published By ThinkHR.com
by admin | May 16, 2018 | Benefit Management, Group Benefit Plans, Human Resources
Curious about when you should notify a participant about a change to their health care plan?
The answer is that it depends!
Notification must happen within one of three time frames: 60 days prior to the change, no later than 60 days after the change, or within 210 days after the end of the plan year.
For modifications to the summary plan description (SPD) that constitute a material reduction in covered services or benefits, notice is required within 60 days prior to or after the adoption of the material reduction in group health plan services or benefits. (For example, a decrease in employer contribution is a material reduction in covered services or benefits. So is a material modification in any plan terms affecting the content of the most recent summary of benefits and coverage (SBC).) While the rule here is flexible, the definite best practice is to give advance notice. For collective practical purposes, employees should be told prior to the first increased withholding.
However, if the change is part of open enrollment, and communicated during open enrollment, this is considered acceptable notice regardless of whether the SBC, SPD, or both are changing. Essentially, open enrollment is a safe harbor for all 60-day prior/60-day post notice requirements.
Finally, changes that do not affect the SBC and are not a material reduction in benefits must be communicated and summarized within 210 days after the end of the plan year.
By Danielle Capilla
Originally published by www.UBABenefits.com
by admin | Apr 18, 2018 | Employee Benefits, Human Resources
Did you know that you can save time and money on your prescription drugs by simply signing up for a discount card online? With savings as much as 80% off, these discount cards keep your health care costs down even when the prices of prescriptions are sharply rising. At no cost to the patient, discount drug programs negotiate the price of medicines with pharmacies and then pass the savings on to the consumer. These programs give subscribers a personalized discount card to be used at any pharmacy. While the discount card cannot be used in conjunction with health insurance, the consumer may see that the cost of their medicine is actually LESS with the card than it is with their insurance.
Another benefit to the consumer is that these programs will publish at which pharmacy you can find your medicine. This is especially helpful to the person who has specialty drug prescriptions. For example, Rebekah is prescribed a specialty drug for pain and neuropathy due to Multiple Sclerosis. This drug is not commonly stocked in pharmacies and so many times, she has had to wait for them to order it. By using the discount drug program, Rebekah is able to see which pharmacies have her medicine in stock and the estimated price.
So where do you start? Here are a few discount drug programs to investigate costs and providers for your prescriptions:
- staterxplans.us
- Provides free drug cards to reduce the out-of-pocket cost of prescription drugs.
- Click on your state and the site will redirect you to your corresponding prescription assistance program.
- goodrx.com
- Compares prices and discounts at thousands of pharmacies.
- Receive coupons via phone, email, or text to print or present for discounts.
- refillwise.com
- Free drug card to present at pharmacy for cost savings on prescriptions.
- Earn rewards each time you use their card—similar to credit card rewards. Each fill is 500 points and when you reach 5,000 points, you earn a gift card to various retailers.
Being a savvy consumer can save you money! Shop around to find the best cost for your prescription drugs and save time by locating the pharmacy that has your meds in stock. Discount drug programs are a great resource so do your research and find one that fits your needs.
by admin | Apr 13, 2018 | ACA, Benefit Management, Group Benefit Plans
States that permit carriers to renew medical policies without adopting various Affordable Care Act (ACA) requirements may continue to do so through 2019, according to a bulletin released April 9, 2018, by the U.S. Department of Health and Human Services. The bulletin extends transitional relief for non-ACA-compliant policies for another year. The affected category of non-ACA-compliant policies, available in some individual and small group insurance markets, is commonly referred to as grandmothered.
By way of background, the ACA imposes numerous requirements on health plans. Whether a specific requirement applies, however, depends in part on the type of plan – and grandfathers and grandmothers are not the same.
Grandfathers
First, a grandfathered health plan is one that was established no later than March 23, 2010, when the ACA was enacted. The plan can maintain grandfathered status indefinitely, as long as it does not make certain changes to reduce its benefits or increase the employee’s out-of-pocket costs. Basic ACA rules, such as coverage for children up to age 26 and prohibiting annual and lifetime dollar limits on essential health benefits, apply to all plans. A plan that maintains grandfathered status, however, is exempt from many other ACA rules, such as coverage mandates for preventive care, and small group market rules for essential health benefits and adjusted community rating.
Grandmothers
A grandmothered policy does not have grandfathered plan status. It is an individual or small group policy originally issued before 2014 that has been allowed to renew year after year in accordance with the state’s insurance laws. Grandmothering does not apply to policies issued in the large group market. Most states that permit grandmothering also limit small group policies to groups with up to 50 employees.
Depending on the specific state’s rules, a grandmothered policy may be exempt from various ACA rules that otherwise would have taken effect in 2014, such as required coverage for all categories of essential health benefits and adjusted community rating. Currently about 30 states allow some type of grandmothering for individual policies or small group policies, or both, but the details vary from state to state.
States that allow grandmothering may continue to do so for renewals through October 1, 2019, provided the policy ends by December 31, 2019. Note, however, that even if the state’s insurance laws allow grandmothering, carriers are not required to continue renewing non-ACA policies.
What This Means
In summary, state insurance laws continue to control the options, provisions, and requirements that apply to group policies issued in their state. (Self-funded plans are not subject to state insurance laws.) For information about your state’s current insurance laws, refer to a carrier or broker that is licensed to sell products in your state.
Originally posted on ThinkHR.com
